InvestorsHub Logo
Post# of 252488
Next 10
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: None

Tuesday, 02/20/2018 8:50:57 AM

Tuesday, February 20, 2018 8:50:57 AM

Post# of 252488
AIMT shares surge (12% /PM) as PhIII peanut allergy study wows on the primary endpoint, setting up FDA pitch
https://endpts.com/aimmune-shares-surge-as-phiii-peanut-allergy-study-scores-on-the-primary-endpoint-setting-up-fda-pitch/

PS—Endpoints has made it very hard to copy/paste blurbs from their site. Have to do it in very small chunks at a time.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.